Ruling out COVID-19 by chest CT at emergency admission when prevalence is low: the prospective, observational SCOUT study.
COVID-19
Computed tomography
Prevalence
Reverse transcriptase polymerase chain reaction
Sensitivity and specificity
Severe acute respiratory syndrome coronavirus 2
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
12 Jan 2021
12 Jan 2021
Historique:
received:
09
10
2020
accepted:
29
12
2020
entrez:
13
1
2021
pubmed:
14
1
2021
medline:
20
1
2021
Statut:
epublish
Résumé
It is essential to avoid admission of patients with undetected corona virus disease 2019 (COVID-19) to hospitals' general wards. Even repeated negative reverse transcription polymerase chain reaction (RT-PCR) results do not rule-out COVID-19 with certainty. The study aimed to evaluate a rule-out strategy for COVID-19 using chest computed tomography (CT) in adults being admitted to the emergency department and suspected of COVID-19. In this prospective, single centre, diagnostic accuracy cohort study, consecutive adults (≥ 18 years) presenting with symptoms consistent with COVID-19 or previous contact to infected individuals, admitted to the emergency department and supposed to be referred to general ward were included in March and April 2020. All participants underwent low-dose chest CT. RT-PCR- and specific antibody tests were used as reference standard. Main outcome measures were sensitivity and specificity of chest CT. Predictive values were calculated based on the theorem of Bayes using Fagan's nomogram. Of 165 participants (56.4% male, 71 ± 16 years) included in the study, the diagnosis of COVID-19 was confirmed with RT-PCR and AB tests in 13 participants (prevalence 7.9%). Sensitivity and specificity of chest CT were 84.6% (95% confidence interval [CI], 54.6-98.1) and 94.7% (95% CI, 89.9-97.7), respectively. Positive and negative likelihood ratio of chest CT were 16.1 (95% CI, 7.9-32.8) and 0.16 (95% CI, 0.05-0.58) and positive and negative predictive value were 57.9% (95% CI, 40.3-73.7) and 98.6% (95% CI, 95.3-99.6), respectively. At a low prevalence of COVID-19, chest CT could be used as a complement to repeated RT-PCR testing for early COVID-19 exclusion in adults with suspected infection before referral to hospital's general wards. Trial registration ClinicalTrials.gov: NCT04357938 April 22, 2020.
Sections du résumé
BACKGROUND
BACKGROUND
It is essential to avoid admission of patients with undetected corona virus disease 2019 (COVID-19) to hospitals' general wards. Even repeated negative reverse transcription polymerase chain reaction (RT-PCR) results do not rule-out COVID-19 with certainty. The study aimed to evaluate a rule-out strategy for COVID-19 using chest computed tomography (CT) in adults being admitted to the emergency department and suspected of COVID-19.
METHODS
METHODS
In this prospective, single centre, diagnostic accuracy cohort study, consecutive adults (≥ 18 years) presenting with symptoms consistent with COVID-19 or previous contact to infected individuals, admitted to the emergency department and supposed to be referred to general ward were included in March and April 2020. All participants underwent low-dose chest CT. RT-PCR- and specific antibody tests were used as reference standard. Main outcome measures were sensitivity and specificity of chest CT. Predictive values were calculated based on the theorem of Bayes using Fagan's nomogram.
RESULTS
RESULTS
Of 165 participants (56.4% male, 71 ± 16 years) included in the study, the diagnosis of COVID-19 was confirmed with RT-PCR and AB tests in 13 participants (prevalence 7.9%). Sensitivity and specificity of chest CT were 84.6% (95% confidence interval [CI], 54.6-98.1) and 94.7% (95% CI, 89.9-97.7), respectively. Positive and negative likelihood ratio of chest CT were 16.1 (95% CI, 7.9-32.8) and 0.16 (95% CI, 0.05-0.58) and positive and negative predictive value were 57.9% (95% CI, 40.3-73.7) and 98.6% (95% CI, 95.3-99.6), respectively.
CONCLUSION
CONCLUSIONS
At a low prevalence of COVID-19, chest CT could be used as a complement to repeated RT-PCR testing for early COVID-19 exclusion in adults with suspected infection before referral to hospital's general wards. Trial registration ClinicalTrials.gov: NCT04357938 April 22, 2020.
Identifiants
pubmed: 33435973
doi: 10.1186/s12931-020-01611-w
pii: 10.1186/s12931-020-01611-w
pmc: PMC7802980
doi:
Banques de données
ClinicalTrials.gov
['NCT04357938']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
13Références
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
J Med Virol. 2020 Jul;92(7):891-902
pubmed: 32314805
Lancet Infect Dis. 2020 Sep;20(9):1043-1050
pubmed: 32539988
Acad Emerg Med. 1996 Sep;3(9):895-900
pubmed: 8870764
Arch Physiother. 2019 Mar 7;9:4
pubmed: 30891312
Radiology. 2020 Sep;296(3):E145-E155
pubmed: 32301646
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Invest Radiol. 2020 May;55(5):257-261
pubmed: 32091414
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
J Prev Med Public Health. 2020 May;53(3):151-157
pubmed: 32498136
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
J Thorac Imaging. 2020 Jul;35(4):219-227
pubmed: 32324653
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
N Engl J Med. 1975 Jul 31;293(5):257
pubmed: 1143310
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
AJR Am J Roentgenol. 2020 Jul;215(1):87-93
pubmed: 32174129
Radiology. 2020 Aug;296(2):E55-E64
pubmed: 32191587
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353